August 15, 2018
The 89th edition of the HPRA Drug Safety Newsletter.
The 89th edition of the HPRA Drug Safety Newsletter (DSN) includes important updates to support safe and appropriate use of the following medicines:
Xofigo (radium-223 dichloride) – New restrictions for use
Varenicline (Champix) – Product Information Update – Reports of Transient Loss of Consciousness
Oral Methotrexate – Updates to Product Information
Adverse Reaction Reporting – Update